Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-002517
Filing Date
2026-01-05
Accepted
2026-01-05 16:30:21
Documents
1
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10390
  Complete submission text file 0001193125-26-002517.txt   11803
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XILIO THERAPEUTICS, INC. 828 WINTER STREET WALTHAM MA 02451
Business Address
Frankenfield Christopher James (Reporting) CIK: 0001988344 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 26506783